Veterinary Diagnostics Market (By Product: Consumables, Reagents & Kits, Instruments & Devices; By Species: Bovine, Camelid, Canine and Feline, Caprine, Equine, Ovine, Porcine, Avian, Others; By Testing Category: Analytical Services, Diagnostic Imaging, Bacteriology, Pathology, Molecular Diagnostics, Immunoassays, Parasitology, Serology, Virology; By Disease Type: Infectious Diseases, Non-infectious Diseases, Hereditary, Congenital, and Acquired Diseases, General Ailments, Structural and Functional Diseases; By End-use: Laboratories, Veterinary Hospitals and Clinics, Point-Of-Care/In-House Testing, Research Institutes and Universities) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Published Date : Aug 2021 | No. of Pages : 250 Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Diagnostics Market, By Product

7.1.  Veterinary Diagnostics Market, By Product, 2020-2030

7.1.1.    Consumables, Reagents & Kits

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Instruments & Devices

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Veterinary Diagnostics Market, By Species

8.1.  Veterinary Diagnostics Market, By Species, 2020-2030

8.1.1.    Bovine

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Camelid

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Canine and Feline

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Caprine

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Equine

8.1.5.1.        Market Revenue and Forecast (2016-2030)

8.1.6.    Ovine

8.1.6.1.        Market Revenue and Forecast (2016-2030)

8.1.7.    Porcine

8.1.7.1.        Market Revenue and Forecast (2016-2030)

8.1.8.    Avian

8.1.8.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Veterinary Diagnostics Market, By Testing Category

9.1.  Veterinary Diagnostics Market, By Testing Category, 2020-2030

9.1.1.    Analytical Services

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Diagnostic Imaging

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Bacteriology

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Pathology

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Molecular Diagnostics

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    Immunoassays

9.1.6.1.        Market Revenue and Forecast (2016-2030)

9.1.7.    Parasitology

9.1.7.1.        Market Revenue and Forecast (2016-2030)

9.1.8.    Serology

9.1.8.1.        Market Revenue and Forecast (2016-2030)

9.1.9.    Virology

9.1.9.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Veterinary Diagnostics Market, By Disease Type

10.1.        Veterinary Diagnostics Market, By Disease Type, 2020-2030

10.1.1.  Infectious Diseases

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Non-infectious Diseases

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Hereditary, Congenital, and Acquired Diseases

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  General Ailments

10.1.4.1.      Market Revenue and Forecast (2016-2030)

10.1.5.  Structural and Functional Diseases

10.1.5.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Veterinary Diagnostics Market, By End-Use

11.1.        Veterinary Diagnostics Market, By End-Use, 2020-2030

11.1.1.  Laboratories

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Veterinary Hospitals and Clinics

11.1.2.1.      Market Revenue and Forecast (2016-2030)

11.1.3.  Point-Of-Care/In-House Testing

11.1.3.1.      Market Revenue and Forecast (2016-2030)

11.1.4.  Research Institutes and Universities

11.1.4.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Veterinary Diagnostics  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, By Product (2016-2030)

12.1.2.  Market Revenue and Forecast, By Species (2016-2030)

12.1.3.  Market Revenue and Forecast, By Testing Category (2016-2030)

12.1.4.  Market Revenue and Forecast, By Disease Type (2016-2030)

12.1.5.  Market Revenue and Forecast, By End-Use (2016-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, By Product (2016-2030)

12.1.6.2.      Market Revenue and Forecast, By Species (2016-2030)

12.1.6.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.1.6.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.1.6.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, By Product (2016-2030)

12.1.7.2.      Market Revenue and Forecast, By Species (2016-2030)

12.1.7.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.1.7.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.1.7.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, By Product (2016-2030)

12.2.2.  Market Revenue and Forecast, By Species (2016-2030)

12.2.3.  Market Revenue and Forecast, By Testing Category (2016-2030)

12.2.4.  Market Revenue and Forecast, By Disease Type (2016-2030)

12.2.5.  Market Revenue and Forecast, By End-Use (2016-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, By Product (2016-2030)

12.2.6.2.      Market Revenue and Forecast, By Species (2016-2030)

12.2.6.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.2.6.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.2.6.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, By Product (2016-2030)

12.2.7.2.      Market Revenue and Forecast, By Species (2016-2030)

12.2.7.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.2.7.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.2.7.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, By Product (2016-2030)

12.2.8.2.      Market Revenue and Forecast, By Species (2016-2030)

12.2.8.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.2.8.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.2.8.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, By Product (2016-2030)

12.2.9.2.      Market Revenue and Forecast, By Species (2016-2030)

12.2.9.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.2.9.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.2.9.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, By Product (2016-2030)

12.3.2.  Market Revenue and Forecast, By Species (2016-2030)

12.3.3.  Market Revenue and Forecast, By Testing Category (2016-2030)

12.3.4.  Market Revenue and Forecast, By Disease Type (2016-2030)

12.3.5.  Market Revenue and Forecast, By End-Use (2016-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, By Product (2016-2030)

12.3.6.2.      Market Revenue and Forecast, By Species (2016-2030)

12.3.6.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.3.6.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.3.6.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, By Product (2016-2030)

12.3.7.2.      Market Revenue and Forecast, By Species (2016-2030)

12.3.7.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.3.7.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.3.7.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, By Product (2016-2030)

12.3.8.2.      Market Revenue and Forecast, By Species (2016-2030)

12.3.8.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.3.8.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.3.8.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, By Product (2016-2030)

12.3.9.2.      Market Revenue and Forecast, By Species (2016-2030)

12.3.9.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.3.9.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.3.9.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, By Product (2016-2030)

12.4.2.  Market Revenue and Forecast, By Species (2016-2030)

12.4.3.  Market Revenue and Forecast, By Testing Category (2016-2030)

12.4.4.  Market Revenue and Forecast, By Disease Type (2016-2030)

12.4.5.  Market Revenue and Forecast, By End-Use (2016-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, By Product (2016-2030)

12.4.6.2.      Market Revenue and Forecast, By Species (2016-2030)

12.4.6.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.4.6.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.4.6.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, By Product (2016-2030)

12.4.7.2.      Market Revenue and Forecast, By Species (2016-2030)

12.4.7.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.4.7.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.4.7.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, By Product (2016-2030)

12.4.8.2.      Market Revenue and Forecast, By Species (2016-2030)

12.4.8.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.4.8.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.4.8.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, By Product (2016-2030)

12.4.9.2.      Market Revenue and Forecast, By Species (2016-2030)

12.4.9.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.4.9.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.4.9.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, By Product (2016-2030)

12.5.2.  Market Revenue and Forecast, By Species (2016-2030)

12.5.3.  Market Revenue and Forecast, By Testing Category (2016-2030)

12.5.4.  Market Revenue and Forecast, By Disease Type (2016-2030)

12.5.5.  Market Revenue and Forecast, By End-Use (2016-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, By Product (2016-2030)

12.5.6.2.      Market Revenue and Forecast, By Species (2016-2030)

12.5.6.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.5.6.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.5.6.5.      Market Revenue and Forecast, By End-Use (2016-2030)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, By Product (2016-2030)

12.5.7.2.      Market Revenue and Forecast, By Species (2016-2030)

12.5.7.3.      Market Revenue and Forecast, By Testing Category (2016-2030)

12.5.7.4.      Market Revenue and Forecast, By Disease Type (2016-2030)

12.5.7.5.      Market Revenue and Forecast, By End-Use (2016-2030)

Chapter 13.  Company Profiles

13.1.              Abaxis, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Idexx Laboratories, Inc.

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Heska Corporation

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Neogen Corp

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Merck

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Thermo Fisher Scientific, Inc

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Qiagen N.V.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Virbac Corp

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Zoetis, Inc.

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           IDVet

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

13.11.           Agrolabo SPA

13.11.1.               Company Overview

13.11.2.               Product Offerings

13.11.3.               Financial Performance

13.11.4.               Recent Initiatives

13.12.           Im3 Inc.

13.12.1.               Company Overview

13.12.2.               Product Offerings

13.12.3.               Financial Performance

13.12.4.               Recent Initiatives

13.13.           VCA Antech

13.13.1.               Company Overview

13.13.2.               Product Offerings

13.13.3.               Financial Performance

13.13.4.               Recent Initiatives

13.14.           Henry Schein, Inc.

13.14.1.               Company Overview

13.14.2.               Product Offerings

13.14.3.               Financial Performance

13.14.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Blood Group Typing Market (By Product: Consumables, Instruments; By Techniques: PCR-based & Microarray, Assay-based; By Test Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Fill-finish Pharmaceutical Contract Manufacturing Market (By Product Type: Prefilled Syringes, Vials, Cartridges; By Molecule Type; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Dental Biomaterials Market (By Type: Metallic, Ceramic, Polymeric; By Application: Orthodontics, Implantology, Prosthodontics; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Sterile Tubing Welder Market (By Mode: Automatic, Manual; By Application: Biopharmaceutical, Blood Processing; By End Use: Hospitals, Research Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Skin Antiseptic Products Market (By Formulations: Alcohols, Chlorhexidine; By Type: Solutions, Swab Sticks, Wipes; By Application: Surgeries, Injections) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...